- Home
- CHEC vs LENZ Comparison
CHEC vs LENZ Comparison
Compare CHEC & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$4.94
Company Overview
Basic Information| Metric | CHEC | LENZ |
|---|---|---|
| Founded | 2024 | 2019 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.5M | 185.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CHEC | LENZ |
|---|---|---|
| Price | $10.19 | $4.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | 9.7K | ★ 977.9K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,088,000.00 |
| Revenue This Year | N/A | $50.42 |
| Revenue Next Year | N/A | $197.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.91 | $4.78 |
| 52 Week High | $10.56 | $50.19 |
Technical Indicators
Market Signals| Indicator | CHEC | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 61.80 | 29.65 |
| Support Level | $10.15 | N/A |
| Resistance Level | $10.47 | $6.21 |
| Average True Range (ATR) | 0.01 | 0.42 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 66.67 | 12.09 |
Price Performance
Historical Comparison CHEC
LENZ
About CHEC Chenghe Acquisition III Co. Class A Ordinary Share
Chenghe Acquisition III Co is blank check company.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.